XTX Topco’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.3K | Buy |
+13,056
| New | +$56.3K | ﹤0.01% | 1997 |
|
|
2024
Q4 | – | Sell |
-1,727
| Closed | -$21.5K | – | 2612 |
|
|
2024
Q3 | $21.5K | Sell |
1,727
-7,645
| -82% | -$95.2K | ﹤0.01% | 1827 |
|
|
2024
Q2 | $122K | Sell |
9,372
-6,817
| -42% | -$88.7K | 0.01% | 1372 |
|
|
2024
Q1 | $367K | Buy |
16,189
+12,914
| +394% | +$293K | 0.05% | 679 |
|
|
2023
Q4 | $42.5K | Sell |
3,275
-17,396
| -84% | -$226K | 0.01% | 1256 |
|
|
2023
Q3 | $415K | Sell |
20,671
-4,919
| -19% | -$98.9K | 0.07% | 510 |
|
|
2023
Q2 | $687K | Buy |
+25,590
| New | +$687K | 0.12% | 218 |
|
|
2023
Q1 | – | Sell |
-8,721
| Closed | -$445K | – | 1476 |
|
|
2022
Q4 | $445K | Buy |
8,721
+6,018
| +223% | +$307K | 0.09% | 356 |
|
|
2022
Q3 | $221K | Sell |
2,703
-737
| -21% | -$60.3K | 0.05% | 722 |
|
|
2022
Q2 | $233K | Buy |
3,440
+2,478
| +258% | +$168K | 0.1% | 400 |
|
|
2022
Q1 | $106K | Buy |
962
+92
| +11% | +$10.1K | 0.05% | 504 |
|
|
2021
Q4 | $84K | Sell |
870
-215
| -20% | -$20.8K | 0.05% | 495 |
|
|
2021
Q3 | $95K | Buy |
+1,085
| New | +$95K | 0.03% | 568 |
|